Skip to content
Medical Health Aged Care

RACGP welcomes Government support for nationally consistent rules for ADHD prescribing

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs has welcomed the Australian Government's support for nationally consistent rules for prescribing medication for Australians living with attention deficit hyperactivity disorder (ADHD). 

It came in the Government’s response to the Senate Community Affairs References Committee report: Assessment and support services for people with attention deficit hyperactivity disorder (ADHD), released yesterday. 

RACGP President Dr Michael Wright said: “The current lack of consistency for ADHD prescribing is a major barrier to timely care and management for patients. 

“We strongly welcome the Government’s support for a nationally consistent approach that helps adults and children with ADHD access appropriate and early support from their GP, including reducing regulatory barriers for prescribing stimulant medications. 

“Enabling GPs across Australia to better support people living with ADHD will increase access to assessment and treatment, improve the health and wellbeing of patients, as well as reducing wait times and costs, and easing pressure elsewhere in the health system. 

“Currently, people with ADHD face significant barriers to care, including long wait times and high costs for assessment, diagnosis and treatment.  

“I’ve heard of patients waiting months and paying hundreds of dollars to confirm their ADHD diagnosis. And then having to go back to see a psychiatrist for scripts that could be easily and safely prescribed by their GP. This reduction in regulation is important to allow patients to easily access care that they need - with a GP who knows them at their local general practice 

“With new ADHD clinical guidelines from the Australasian ADHD Professionals Association, GPs have a comprehensive, evidence-based resource to assist diagnosis and management of ADHD – we can help improve access and reduce costs for patients and ease our stretched health system. 

“Increasing patients’ Medicare rebates for longer consultations will also improve access to care. Currently people who have complex health issues, including patients with ADHD, are disadvantaged by low government subsidies for longer consults, meaning they have higher out-of-pocket costs. This is an investment in the health of our nation, because when patients can spend the time they need with their GP, they have better health outcomes.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992[email protected]

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 18/04/2025
  • 07:00
Monash University

Experts warn of increased alcohol harms over the Easter long weekend

Heavy alcohol consumption is usually associated with the summer months, not with Easter. But new analysis of Victorian ambulance data shows that there are regularly more than 500 alcohol-related attendances over the Easter long weekend. This heightened level of alcohol harm means the upcoming four-day weekend is the equivalent of four successive Saturday nights, and Victorians should consider their alcohol consumption and plan to stay safe as they prepare for Easter. The analysis reaffirms the findings of other projects led by the National Ambulance Surveillance System (NASS) at Turning Point and Monash University. VicHealth-funded research into the 2022 calendar year…

  • Contains:
  • Medical Health Aged Care
  • 17/04/2025
  • 23:26
Avania

Avania Strengthens Leadership Team With Pivotal Executive Appointments

BILTHOVEN, Netherlands & BOSTON–BUSINESS WIRE– Avania — the leading global MedTech advisory and clinical development partner — today announced the appointments of Jasmine Saba…

  • Contains:
  • Medical Health Aged Care
  • 17/04/2025
  • 22:11
Tilray Brands, Inc.

Tilray Medical Introduces Cannabis Edibles in Australia

Tilray Medical Expands Offerings with Good Supply Brand Medical Cannabis Pastilles for Australian PatientsSYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.Denise Faltischek, Chief Strategy Officer and Head of…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.